IRIS
RAFANIELLO, Concetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.045
AS - Asia 2.535
NA - Nord America 2.330
SA - Sud America 443
AF - Africa 29
OC - Oceania 2
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.279
RU - Federazione Russa 1.959
SG - Singapore 834
IE - Irlanda 668
CN - Cina 640
IT - Italia 442
BR - Brasile 379
HK - Hong Kong 373
DE - Germania 246
GB - Regno Unito 230
VN - Vietnam 214
UA - Ucraina 172
KR - Corea 116
JP - Giappone 111
IN - India 90
FI - Finlandia 71
SE - Svezia 56
TR - Turchia 56
GR - Grecia 51
FR - Francia 27
AR - Argentina 26
AT - Austria 23
CA - Canada 22
BE - Belgio 20
ID - Indonesia 18
BD - Bangladesh 16
IQ - Iraq 15
MX - Messico 15
NL - Olanda 14
EC - Ecuador 12
ES - Italia 12
ZA - Sudafrica 12
CZ - Repubblica Ceca 11
IR - Iran 10
KG - Kirghizistan 7
LT - Lituania 7
CO - Colombia 6
IL - Israele 6
JM - Giamaica 6
PK - Pakistan 6
PL - Polonia 6
PY - Paraguay 6
DK - Danimarca 5
MA - Marocco 5
PE - Perù 5
RS - Serbia 5
AL - Albania 4
CH - Svizzera 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CL - Cile 3
DO - Repubblica Dominicana 3
NP - Nepal 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
ET - Etiopia 2
JO - Giordania 2
NO - Norvegia 2
PR - Porto Rico 2
QA - Qatar 2
RO - Romania 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AQ - Antartide 1
AU - Australia 1
BB - Barbados 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZM - Zambia 1
Totale 9.386
Salva come PNG Salva come JPEG
Città #
Dublin 663
Moscow 660
Singapore 415
Hong Kong 372
Santa Clara 354
Jacksonville 266
Chandler 256
Ashburn 121
Beijing 120
Seoul 114
Hefei 102
Ann Arbor 88
Naples 78
Princeton 75
Roxbury 67
Dong Ket 66
Medford 60
Bremen 57
Aversa 56
Bengaluru 54
Woodbridge 49
Munich 48
Ho Chi Minh City 45
Hanoi 43
New York 42
Düsseldorf 40
Wilmington 40
Caserta 37
The Dalles 32
Dearborn 28
São Paulo 27
Nanjing 26
Cambridge 25
Boardman 23
Mountain View 23
Dallas 22
Des Moines 21
Los Angeles 21
Brussels 19
Hanover 18
Genoa 17
Kunming 16
Milan 16
San Mateo 16
Jinan 15
Auburn Hills 14
Curitiba 12
Helsinki 12
Jakarta 12
Napoli 12
Turku 12
Brno 11
London 11
Vienna 11
Guangzhou 10
Nuremberg 10
Rome 10
Brasília 9
Changsha 9
Columbus 9
Frankfurt am Main 9
Messina 9
Nanchang 9
Pomigliano d'Arco 9
Atlanta 8
Belo Horizonte 8
Biên Hòa 8
Falkenstein 8
Guarulhos 8
Johannesburg 8
Salerno 8
Tokyo 8
Toronto 8
Da Nang 7
Mexico City 7
Norwalk 7
Bishkek 6
Houston 6
Manchester 6
Redwood City 6
Rio de Janeiro 6
Shenyang 6
Stockholm 6
Tel Aviv 6
Wuhan 6
Zhengzhou 6
Amsterdam 5
Avellino 5
Baghdad 5
Cagliari 5
Chengdu 5
Chennai 5
Chicago 5
Guayaquil 5
Haiphong 5
Hebei 5
Lappeenranta 5
Montreal 5
Newark 5
San Francisco 5
Totale 5.176
Salva come PNG Salva come JPEG
Nome #
Adverse drug reactions and gender differences: What changes in drug safety? 161
Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy 147
Bisphosphonate-related osteonecrosis of the jaw: an italian post-marketing surveillance analysis 146
Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study 144
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 132
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 131
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 129
Effects of chronic administration of β-blockers on airway responsiveness in a murine model of heart failure. 128
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: A population-based study. 127
Therapeutic drug monitoring of second-generation antipsychotics in pediatric patients: An observational study in real-life settings 123
Complete resistance after maximal dose of rocuronium 121
Medication adherence and the use of new pharmaceutical formulations: The case of levothyroxine 120
Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. 119
Cardiorespiratory effects of change in posture after spinal anesthesia with hyperbaric bupivacaine 117
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 116
Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis 114
Metabolic syndrome and postmenopausal breast cancer: systematic review and meta-analysis 114
Pattern of statin use in southern Italian primary care: Can prescription databases be used for monitoring long-term adherence to the treatment? 114
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 114
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 113
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 111
Survival from coma induced by an intentional 36-g overdose of extended-release quetiapine 108
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting system 108
Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy. 107
Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation 107
Vitamin D deficiency in type 2 diabetic patients with hypogonadism. 106
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 106
Effects of ranolazine in a model of doxorubicin-induced left ventricle diastolic dysfunction 104
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 104
Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study 103
The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy 100
Association between Sex-Related ALOX5 Gene Polymorphisms and Lung Atopy Risk 99
Deficit of glucocorticoid-induced leucine zipper amplifies angiotensin-induced cardiomyocyte hypertrophy and diastolic dysfunction 99
Disclosing negative trial results – procedure 98
Targeting high glucose-induced epigenetic modifications at cardiac level: the role of SGLT2 and SGLT2 inhibitors 97
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 97
COVID-19 and atrial fibrillation: Intercepting lines 97
Current pharmacological treatments for COVID-19: What's next? 97
Vaccine effectiveness against severe laboratory-confirmed influenza in children: Results of two consecutive seasons in Italy 96
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 96
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary 95
Safety of attention-deficit/hyperactivity disorder medications in children: an intensive pharmacosurveillance monitoring study. 95
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System 95
Persistence in therapy with risperidone and aripiprazole in pediatric outpatients: A 2-year naturalistic comparison 94
Did the new Italian law on mandatory vaccines affect adverse event Following immunization's reporting? A pharmacovigilance study in Southern Italy 94
Utilizing clinical pharmacology in the drug repurposing arena: a look into COVID-19 92
Drug use and upper gastrointestinal complications in children: a case-control study 92
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switch 92
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines 91
Late relapse after CAR-T cell therapy for adult patients with hematologic malignancies: A definite evidence from systematic review and meta-analysis on individual data 90
Hospital consumption of antibiotics at the Policlinico Hospital of the Second University of Naples: results of retrospective data collection 89
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 88
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 88
Neurological Manifestations Related to Immune Checkpoint Inhibitors: Reverse Translational Research by Using the European Real-World Safety Data 87
Alginate-Based Composites for Corneal Regeneration: The Optimization of a Biomaterial to Overcome Its Limits 86
Did the COVID-19 Pandemic Affect Contrast Media-Induced Adverse Drug Reaction’s Reporting? A Pharmacovigilance Study in Southern Italy 86
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 85
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 85
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 85
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 83
Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study 83
DPP-4 inhibitors: Pharmacological differences and their clinical implications 83
Hyaluronic acid-based fillers in patients with autoimmune inflammatory diseases 82
Effectiveness and safety of the A-H1N1 vaccine in children: a hospital-based case-control study 82
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 82
Rational use of antibiotics for the management of children's respiratory tract infections in the ambulatory setting: An evidence-based consensus by the Italian Society of Preventive and Social Pediatrics 81
SAFETY AND TOLERABILITY OF ADHD MEDICATIONS: AN INTENSIVE MONITORING PROGRAMME IN THE CAMPANIA REGION 80
Multisystem Inflammatory Syndrome in Children Following COVID-19 Vaccination: A Sex-Stratified Analysis of the VAERS Database Using Brighton Collaboration Criteria 79
Pregnancy Recommendations Solely Based on Preclinical Evidence Should Be Integrated with Real-World Evidence: A Disproportionality Analysis of Certolizumab and Other TNF-Alpha Inhibitors Used in Pregnant Patients with Psoriasis 78
Uncovering prognostic biomarkers through a pharmacovigilance study: the case of RDW 78
Indications of newer and older anti-epileptic drug use: Findings from a southern Italian general practice setting from 2005-2011 78
Strengths, weaknesses and future challenges of biosimilars’ development. An opinion on how to improve the knowledge and use of biosimilars in clinical practice 76
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 75
A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database 75
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 74
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 74
Renin-angiotensin system and coronavirus disease 2019: A narrative review 73
Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug-induced liver injury case–control study in Italy 72
Therapeutic strategies to fight COVID-19: Which is the status artis? 72
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 71
The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions 70
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 70
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 69
miRNA Signatures in Alveolar Macrophages Related to Cigarette Smoke: Assessment and Bioinformatics Analysis 69
No substantial gender differences in suspected adverse reactions to ACE inhibitors and ARBs: results from spontaneous reporting system in Campania Region 68
Drugs approved for the treatment of multiple sclerosis: review of their safety profile 68
Tisagenlecleucel in children and young adults: Reverse translational research by using real‐world safety data 68
Drugs-induced pathological gambling: An analysis of italian spontaneous reporting system 67
Surveillance of adverse events following immunization related to human papillomavirus vaccines: 12 years of vaccinovigilance in Southern Italy 67
Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting 65
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 64
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 64
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 64
Drug Utilization and Measurement of Medication Adherence: A Real World Study of Psoriasis in Italy 64
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator 63
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 62
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 61
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database 60
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 59
Cross-national comparison of antiepileptic drug use: Catalonia, Denmark and Norway, 2007-2011 58
Totale 9.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 0 0 0 0 0 7 60 36 10 36 68 76
2021/2022495 19 8 5 5 172 23 13 16 23 25 32 154
2022/20231.279 127 38 18 94 115 89 12 64 626 15 56 25
2023/2024597 43 16 44 41 173 44 13 68 13 17 39 86
2024/20251.781 14 40 25 52 221 255 315 154 244 151 132 178
2025/20263.840 351 421 357 369 703 1.639 0 0 0 0 0 0
Totale 9.597